These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12502928)

  • 61. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
    Hung YP; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sphingosine-1-phosphate receptor 1 is a useful adjunct for distinguishing vascular neoplasms from morphological mimics.
    Akiyama T; Hamazaki S; Monobe Y; Nishimura H; Irei I; Sadahira Y
    Virchows Arch; 2009 Feb; 454(2):217-22. PubMed ID: 19005676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytokeratin expression in epithelioid vascular neoplasms.
    Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
    Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues.
    Remotti F; Fetsch JF; Miettinen M
    Hum Pathol; 2001 Aug; 32(8):873-9. PubMed ID: 11521233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endothelial cell tumors.
    Bell CD
    Microsc Res Tech; 2003 Feb; 60(2):165-70. PubMed ID: 12539170
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment.
    Khan JA; Maki RG; Ravi V
    J Clin Oncol; 2018 Jan; 36(2):194-201. PubMed ID: 29220293
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathology of cutaneous vascular tumors.
    Johnson WC
    Int J Dermatol; 1976 May; 15(4):239-70. PubMed ID: 178614
    [No Abstract]   [Full Text] [Related]  

  • 69. Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells.
    Lee SC; Na YP; Lee JB
    J Am Acad Dermatol; 2003 Sep; 49(3):487-91. PubMed ID: 12963914
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histopathology of Spindle Cell Vascular Tumors.
    Marušić Z; Billings SD
    Surg Pathol Clin; 2017 Jun; 10(2):345-366. PubMed ID: 28477885
    [TBL] [Abstract][Full Text] [Related]  

  • 72. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
    Sirgi KE; Wick MR; Swanson PE
    Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
    Gratzinger D; Zhao S; West R; Rouse RV; Vogel H; Gil EC; Levy R; Lossos IS; Natkunam Y
    Am J Clin Pathol; 2009 Feb; 131(2):264-78. PubMed ID: 19141387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
    Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
    Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinicopathological features of Kaposiform hemangioendothelioma.
    Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
    Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
    Pammer J; Plettenberg A; Weninger W; Diller B; Mildner M; Uthman A; Issing W; Stürzl M; Tschachler E
    Am J Pathol; 1996 May; 148(5):1387-96. PubMed ID: 8623911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of the CD40 antigen on normal endothelial cells and in benign and malignant tumours of vascular origin.
    Pammer J; Weninger W; Mazal PR; Horvat R; Tschachler E
    Histopathology; 1996 Dec; 29(6):517-24. PubMed ID: 8971558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin.
    Kuhn A; Brachtendorf G; Kurth F; Sonntag M; Samulowitz U; Metze D; Vestweber D
    J Invest Dermatol; 2002 Dec; 119(6):1388-93. PubMed ID: 12485444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spindle cell haemangioendothelioma--an acquired vascular lesion of uncertain nature.
    Kumarasinghe MP; Bian NS; Hai LB
    Ceylon Med J; 1999 Jun; 44(2):89-91. PubMed ID: 10565076
    [No Abstract]   [Full Text] [Related]  

  • 80. Histogenesis of Kaposi's sarcoma and angiosarcoma of the face and the scalp.
    Holden CA
    J Invest Dermatol; 1989 Aug; 93(2 Suppl):119S-124S. PubMed ID: 2666517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.